Marc‐Elie Nader

510 total citations
43 papers, 278 citations indexed

About

Marc‐Elie Nader is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Marc‐Elie Nader has authored 43 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Otorhinolaryngology. Recurrent topics in Marc‐Elie Nader's work include Ear and Head Tumors (19 papers), Brain Metastases and Treatment (8 papers) and Meningioma and schwannoma management (7 papers). Marc‐Elie Nader is often cited by papers focused on Ear and Head Tumors (19 papers), Brain Metastases and Treatment (8 papers) and Meningioma and schwannoma management (7 papers). Marc‐Elie Nader collaborates with scholars based in United States, Canada and Italy. Marc‐Elie Nader's co-authors include Paul W. Gidley, Issam Saliba, Yves Théorêt, Diana Bell, Tony Leroux, Lawrence E. Ginsberg, Eric N. Appelbaum, Martin Desrosiers, Shirley Y. Su and Franco DeMonte and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Marc‐Elie Nader

38 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc‐Elie Nader United States	11	96	87	85	61	53	43	278
Vivian F. Kaul United States	9	123 1.3×	49 0.6×	133 1.6×	52 0.9×	23 0.4×	37	271
Mehmet Düzlü Türkiye	13	95 1.0×	78 0.9×	91 1.1×	42 0.7×	26 0.5×	38	313
Sung Joon Park South Korea	12	106 1.1×	63 0.7×	112 1.3×	54 0.9×	41 0.8×	38	329
Ashish Vashishth India	11	252 2.6×	68 0.8×	131 1.5×	38 0.6×	54 1.0×	18	320
Çiǧdem Tepe Karaca Türkiye	11	133 1.4×	33 0.4×	117 1.4×	60 1.0×	38 0.7×	35	319
Faruk Merıç Türkiye	10	197 2.1×	31 0.4×	104 1.2×	70 1.1×	39 0.7×	34	331
Jennifer L. Spiegel Germany	11	72 0.8×	85 1.0×	101 1.2×	34 0.6×	67 1.3×	50	325
Guillaume Buiret France	9	152 1.6×	44 0.5×	136 1.6×	76 1.2×	32 0.6×	51	292
Veit M. Hofmann Germany	10	68 0.7×	48 0.6×	68 0.8×	19 0.3×	45 0.8×	31	262
Nenad Arsović Serbia	11	158 1.6×	81 0.9×	129 1.5×	48 0.8×	86 1.6×	48	393

Countries citing papers authored by Marc‐Elie Nader

Since Specialization

Citations

This map shows the geographic impact of Marc‐Elie Nader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc‐Elie Nader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc‐Elie Nader more than expected).

Fields of papers citing papers by Marc‐Elie Nader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc‐Elie Nader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc‐Elie Nader. The network helps show where Marc‐Elie Nader may publish in the future.

Co-authorship network of co-authors of Marc‐Elie Nader

This figure shows the co-authorship network connecting the top 25 collaborators of Marc‐Elie Nader. A scholar is included among the top collaborators of Marc‐Elie Nader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc‐Elie Nader. Marc‐Elie Nader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gross, Neil D., Marc‐Elie Nader, Renata Ferrarotto, et al.. (2025). Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma. Head & Neck. 48(3). 837–842.

Nader, Marc‐Elie, et al.. (2024). Cisplatin vestibulotoxicity: a current review. Frontiers in Surgery. 11. 1437468–1437468. 2 indexed citations

Nader, Marc‐Elie, Mike Hernández, Katherine A. Hutcheson, et al.. (2024). The Effects of Metformin on Cisplatin‐Induced Ototoxicity in Diabetic Patients. Otolaryngology. 172(1). 243–253.

Nader, Marc‐Elie, Yun Qing, Mike Hernández, et al.. (2024). Losartan May Not Prevent Vestibular Schwannoma Growth or Related Hearing Loss During Observation. Otology & Neurotology. 45(6). 690–695. 1 indexed citations

Qing, Yun, Mike Hernández, Marc‐Elie Nader, et al.. (2023). The Effect of Metformin on Vestibular Schwannoma Growth: A Systematic Review and Meta‐analysis. The Laryngoscope. 133(9). 2066–2072. 1 indexed citations

Nader, Marc‐Elie, et al.. (2023). A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia. Annals of Hematology. 102(12). 3427–3430. 1 indexed citations

Hunt, Patrick J., Moran Amit, Katherine E. Kabotyanski, et al.. (2023). Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies. Neurosurgical Review. 46(1). 157–157.

Han, Albert Y., et al.. (2023). Current status of sinonasal cancer survivorship care. Head & Neck. 45(9). 2458–2468. 4 indexed citations

Hutcheson, Katherine A., et al.. (2023). Hearing loss related outcomes post-lateral temporal bone resection and other oncologic treatment.. Journal of Clinical Oncology. 41(16_suppl). e18069–e18069.

10.

Aggarwal, Puja, Marc‐Elie Nader, Paul W. Gidley, et al.. (2022). Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors. Cancer Medicine. 12(1). 569–583. 3 indexed citations

11.

Gidley, Paul W., et al.. (2022). Audiovestibular Toxicity Secondary to Immunotherapy: Case Series and Literature Review. SHILAP Revista de lepidopterología. 5(1). 2–6. 6 indexed citations

12.

Amit, Moran, Tongxin Xie, Frederico O. Gleber‐Netto, et al.. (2022). Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. Journal of Experimental & Clinical Cancer Research. 41(1). 292–292. 6 indexed citations

13.

Hernández, Mike, et al.. (2021). Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience. The Laryngoscope. 131(11). 2578–2585. 5 indexed citations

14.

Al‐Zubidi, Nagham, Dan S. Gombos, Eric N. Appelbaum, et al.. (2021). Immune-Related Oral, Otologic, and Ocular Adverse Events. Advances in experimental medicine and biology. 1342. 399–416. 4 indexed citations

15.

Chen, Merry, et al.. (2020). Recurrent audiovestibular dysfunction and associated neurological immune‐related adverse events in a melanoma patient treated with nivolumab and ipilimumab. Head & Neck. 42(11). E35–E42. 10 indexed citations

16.

Al‐Zubidi, Nagham, Eric N. Appelbaum, Dan S. Gombos, et al.. (2020). Immune-Related Oral, Otologic, and Ocular Adverse Events. Advances in experimental medicine and biology. 1244. 295–307. 14 indexed citations

17.

Nader, Marc‐Elie, Lawrence E. Ginsberg, Diana Bell, Dianna Roberts, & Paul W. Gidley. (2019). Evaluating Perineural Spread to the Intratemporal Facial Nerve on Magnetic Resonance Imaging. Otolaryngology. 160(6). 1087–1094. 8 indexed citations

18.

Maheu, Maxime, et al.. (2018). Ear Fullness as a Symptom of Endolymphatic Hydrops in non-Ménière’s Patient. The Journal of International Advanced Otology. 13(3). 379–384. 5 indexed citations

19.

Gosselin, Émilie, et al.. (2018). Predictable prosthesis length on a high-resolution CT scan before a stapedotomy. European Archives of Oto-Rhino-Laryngology. 275(9). 2219–2226. 7 indexed citations

20.

Nader, Marc‐Elie, Yves Théorêt, & Issam Saliba. (2010). The role of intratympanic lactate injection in the prevention of cisplatin‐induced ototoxicity. The Laryngoscope. 120(6). 1208–1213. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact